D
Integra LifeSciences Holdings Corporation IART
$16.08 -$0.65-3.89% NASDAQ
Recommendation
Prev Close
$16.73
Volume
725,647
Avg Vol (90D)
639,573
Market Cap
$1.29B
Dividend & Yield
--
52-Week Range
$15.95 - $33.04
P/E (TTM)
--
EPS (TTM)
-$0.0896
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
4/15/2025 - StockStory Articles
Integra Lifesciences Holdings Corp (IART) Shares Down 3.96% on Apr 14
4/14/2025 - GuruFocus
Integra LifeSciences (NASDAQ:IART) Reaches New 52-Week Low on Analyst Downgrade
4/14/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Stock Price Down 7.8% After Analyst Downgrade
4/13/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Given New $19.00 Price Target at Truist Financial
4/13/2025 - MarketBeat
Attention Long-Term Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Investigates Claims on Your Behalf
4/11/2025 - Globe Newswire
Integra LifeSciences Holdings (IART, $17.42) RSI Indicator left the oversold zone on April 10, 2025
4/11/2025 - Tickeron - Technical Analysis
Integra LifeSciences Holdings (IART, $17.42) price may climb as it broke lower Bollinger Band on Apr 10, 2025
4/11/2025 - Tickeron - Technical Analysis
Integra LifeSciences Holdings (IART, $19.19) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Technical Analysis
Norges Bank Acquires New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART)
4/10/2025 - MarketBeat
Do Options Traders Know Something About Integra (IART) Stock We Don't?
4/9/2025 - Zacks Investment Research
Vanguard Group Inc. Trims Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART)
4/8/2025 - MarketBeat
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); General Motors Company (NYSE: GM); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and ModivCare, Inc. (NASDAQ: MODV): Act Now as Grabar Law Office Is Investigating Claims on Your Behalf
4/7/2025 - Globe Newswire
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Price Target at $23.00
4/7/2025 - Ticker Report
15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning AS
4/7/2025 - MarketBeat
Raymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART)
4/6/2025 - MarketBeat
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); ModivCare, Inc. (NASDAQ: MODV); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office is Investigating Claims on Your Behalf
4/4/2025 - Globe Newswire
Integra LifeSciences Holdings (IART, $20.06) price may climb as it broke lower Bollinger Band on Apr 03, 2025
4/4/2025 - Tickeron - Stocks
Integra LifeSciences Holdings (IART, $20.06) RSI Indicator left the oversold zone on April 03, 2025
4/4/2025 - Tickeron - Stocks
156,746 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by Cannell & Spears LLC
4/2/2025 - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts
4/1/2025 - MarketBeat
Integra LifeSciences (NASDAQ:IART) Stock Rating Upgraded by Argus
4/1/2025 - MarketBeat
156,746 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by Cannell & Spears LLC
4/1/2025 - Ticker Report
ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT)
3/31/2025 - Globe Newswire
Integra (IART) Down 7.5% Since Last Earnings Report: Can It Rebound?
3/27/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$1.61B
EBITDA (TTM)
$318.02M
EBIT (TTM)
$177.12M
Net Income (TTM)
-$6.94M
Balance Sheet
Total Assets (Q)
$4.04B
Total Debt (Q)
$1.99B
Total Liabilities (Q)
$2.49B
Book Value Per Share (Q)
$20.03
Cash Flow
Cash from Operations (TTM)
$129.38M
Cash from Investing (TTM)
-$390.81M
Cash from Financing (TTM)
$237.86M
Net Change in Cash (TTM)
-$30.03M
Filings
Filing Date
Tuesday, February 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Created with Highstock 5.0.149. Dec23. Dec6. Jan20. Jan3. Feb17. Feb3. Mar17. Mar31. Mar14. Apr$10.00$20.00$30.00Price as of Apr 14, 2025
Beta
1.07
7-Day Total Return
-17.83%
30-Day Total Return
-26.61%
60-Day Total Return
-33.28%
90-Day Total Return
-34.71%
Year to Date Total Return
-30.15%
1-Year Total Return
-49.84%
2-Year Total Return
-72.63%
3-Year Total Return
-73.83%
5-Year Total Return
-65.93%
52-week Low
Apr 11, 2025 - $15.95
52-week High
Apr 15, 2024 - $33.04
Valuation
Market Cap
$1.29B - Small Cap
Enterprise Value
$3.00B
Price/Sales (TTM)
0.79
Price/Book (Q)
0.84
Dividends and Shares
Shares Outstanding
76.42M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.integralife.com
Phone Number
609 275 0500
Address
1100 Campus Road
Princeton, NJ 08540
Country
United States
Year Founded
1989
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and... more
NASDAQ 04/15/2025 4:00PM Eastern Quotes delayed